Announcements Trials
Browse Landscape

Phase

Phase 2 28Phase NA 7Phase 1/2 3Phase 3 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 22Myelodysplastic Syndromes 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma 12Leukemia 10Multiple Myeloma 9Hodgkin Disease 9Neuroblastoma 8Sarcoma 7Lymphoma, Non-Hodgkin 6Sarcoma, Ewing 5Primary Myelofibrosis 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms, Plasma Cell 5Leukemia, Lymphocytic, Chronic, B-Cell 5Wilms Tumor 4Rhabdomyosarcoma 4Neuroectodermal Tumors, Primitive, Peripheral 4Medulloblastoma 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Hematologic Neoplasms 4Graft vs Host Disease 4Congenital Abnormalities 4Central Nervous System Neoplasms 4Astrocytoma 4Testicular Neoplasms 3Retinoblastoma 3Optic Nerve Glioma 3

Interventions

Filgrastim 17Peripheral Blood Stem Cell Transplantation 15Cyclophosphamide 15fludarabine phosphate 11Rituximab 9Etoposide 8Cyclosporine 8Paclitaxel 7Cytarabine 7Radiotherapy 6Melphalan 6Bortezomib 6tanespimycin 5Vorinostat 5Tacrolimus 5Methylprednisolone 5sargramostim 4aldesleukin 4aflibercept 4Polymerase Chain Reaction 4Mycophenolic Acid 4Leucovorin 4Lenalidomide 4Indium 4Gemcitabine 4Flow Cytometry 4Carmustine 4Carboplatin 4Whole-Body Irradiation 3Topotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Lymphoma, Large-Cell, Immunoblastic × Busulfan × Clear all
NCT00513474 2017-05-25

Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

Massachusetts General Hospital

Phase 1 Completed
46 enrolled 11 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡